Two studies by Adam Savine, the former Washington University neuroscience graduate student found by the Office of Research Integrity to have falsified data, have been retracted.
Here’s the notice for one: Continue reading Retractions arrive for former Wash U neuroscience grad student found to have committed misconduct
Last year, we reported on two retractions and two corrections by a team at the University of Utah. The retractions were because “some of the original data were inappropriately removed from the laboratory.”
At the time, corresponding author Jerry Kaplan told us that:
The data were lost when an employee, who was dismissed, discarded lab notebooks without permission. This occurred prior to the identification of errors in the manuscripts and was reported at that time to the University authorities.
The university would not confirm whether it investigated the case. However, we have now learned that Continue reading Scientists whose papers were retracted and corrected leave University of Utah
A new retraction notice in the Journal of Applied Physiology gives only a hint at the problems in the paper, but what it does say has led us to a story about one of its co-authors.
Here’s the notice, from a team at Duke: Continue reading Former Duke researcher charged with embezzlement has a paper retracted
A fraud investigation at a New York state research institution has led to two retractions of papers looking at genetic links to autism.
The 2011 papers, which appeared in Genes, Brain and Behavior, involve work conducted at the New York State Office for People With Developmental Disabilities’ (OPWDD’s) Institute for Basic Research in Developmental Disabilities, on Staten Island. The last author on both articles is Xiaohong Li, head of the institute’s cellular neurobiology laboratory.
Here’s what the retraction notice has to say: Continue reading Autism genetics papers retracted after fraud inquiry at NY research agency
A group of biologists has lost a paper about a genomics tool after they published the findings twice.
Here’s the notice for the now-retracted paper in BIOS: Continue reading Duplication forces retraction of genomics paper
Here’s a good example of a retraction done the right way (we think).
The Journal of the American Chemical Society has retracted — at the behest of the principal investigator — a 2008 article by a group of researchers whose subsequent studies undermined their confidence in the validity of their initial findings.
The article was titled “Cooperative melting in caged dimers of rigid small molecule DNA-hybrids,” and it came from the lab of SonBinh Nguyen, of Northwestern University. As the paper’s abstract stated:
Continue reading We know why the caged dimers sing: They’re being retracted
Our mothers told us that if we used the masterbatch process, we’d go blind. And what better way to gather some updates to recent posts than to include one that involves said masterbatch process?
First, a retraction John Spevacek noticed when he tried clicking on the link in a Journal of Applied Polymer Science retraction we’d covered: Continue reading A masterbatch: More polymer retractions, gerontology journal lifts paywall, Microbiology notices appear
A technical hiccup led the Journal of Translational Medicine to double publish a 2012 paper by a pair of researchers from China and the United States, leading to a retraction.
The article is/was titled “Opportunities and challenges of disease biomarkers: a new section in the journal of translational medicine,” and it was written by Xiangdong Wang and Peter Ward — both members of the journal’s editorial board. It appeared in the Nov. 7, 2012 issue of the JTM. And it appeared less than a month later, on Dec. 5.
Continue reading Lost from translation(al) medicine: Publisher error leads to retraction
A cancer researcher whose work was the subject of a lawsuit has retracted his fifth paper, this one from 2004.
Robert Getzenberg, formerly of the University of Pittsburgh and Johns Hopkins, has had two papers on prostate cancer biomarkers retracted, and two on colon cancer. The newly retracted paper is about a potential bladder cancer biomarker.
Here’s the notice from Clinical Cancer Research: Continue reading A fifth retraction for former Pitt and Hopkins oncology researcher Getzenberg
A group of University of California, Davis kidney researchers have retracted a paper after being unable to verify key parts of it.
Here’s the detailed retraction notice for “Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels,” published by Limin Wang, George Kaysen, and colleagues in Kidney International last July: Continue reading Kidney International paper retracted after lab records “were improperly filed”